Depomed reported $10.79M in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Aerie Pharmaceuticals AERI:US $ -18.14M 15.51M
Ani Pharmaceuticals ANIP:US $ -12913000 6.28M
Aurora Cannabis Inc ACB:CN -996333000 932.06M
Cara Therapeutics CARA:US $ -4472000 23.44M
Daiichi Sankyo 4568:JP Y 34382M 85129M
Depomed DEPO:US $ 10.79M 0.77M
Ironwood Pharmaceuticals IRWD:US $ 55.66M 2.19M
Johnson & Johnson JNJ:US $ 5840M 22M
Merk MRK:US $ 4927M 642M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Pfizer PFE:US $ 12102M 2229M
Teva Pharmaceutical TEVA:IT -949000000 236M